Veracyte Inc. (VCYT) at a glance

Veracyte Inc. (VCYT) is a mid-cap Healthcare company. It trades at $43.36, with a P/E of 32.3, a 20.4% profit margin and revenue growth of 15.5%. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Safety (18/100). It carries above-market volatility, so expect larger swings.

Price

$43.36

Market cap

$3.48B

P/E ratio

32.3

Dividend yield

None

Beta

1.94

52-week range

$28.55 to $60.91